Abstract
Objective: The description of current treatment possibilities in recurrent ovarian cancer. Design: Review article.
Setting: Obstetrics and Gynecology Department, Charles University 2nd Medical Faculty and University Hospital Motol, Prague. Methods: The review of literature on treatment of recurrent ovarian cancer.
Current data on chemotherapy, surgery and targeted biological therapy in recurrent ovarian cancer. Conclusions: Chemotherapy is indicated in most cases of recurrent ovarian cancer, surgery does not play an important role.
Standard treatment of platinum-sensitive recurrent ovarian cancer is based on platinum combination chemotherapy. Standard treatment of platinum-refractory ovarian cancer represents non-platinum monotherapy.
Targeted biological therapy should be still used only in the studies.